Axis Securities sees India’s diagnostics sector entering a multi-year growth upcycle, supported by rising demand, scalable models and strong cash generation. It initiated BUY coverage on Dr. Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services. 
Axis Securities sees India’s diagnostics sector entering a multi-year growth upcycle, supported by rising demand, scalable models and strong cash generation. It initiated BUY coverage on Dr. Lal PathLabs, Vijaya Diagnostic Centre and Nephrocare Health Services. 
<iframe src="https://hindustansphere.com/embed/cluster/8920032a3c460bc626867c168473f13bc3665b49" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Is India’s diagnostics sector poised for a long-term growth upswing? Axis Securities sees opportunity in three stocks"></iframe>
